MDEVICE Co., Ltd

As of June 30, 2026, MDEVICE Co., Ltd carries a market capitalization of 139.26B, placing it among publicly traded companies globally. Its enterprise value stands at 143.07B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, MDEVICE Co., Ltd has 10.63M shares outstanding.

As of June 30, 2026, MDEVICE Co., Ltd trades at a trailing price-to-earnings ratio of 10.73. The price-to-sales ratio is 1.40, and the price-to-book ratio stands at 2.63.

As of June 30, 2026, MDEVICE Co., Ltd trades at an EV/EBITDA multiple of 9.14 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.44 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 10.14 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 143.07B versus a market cap of 139.26B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, MDEVICE Co., Ltd maintains a current ratio of 1.60, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 64.98, indicating elevated leverage, while an interest coverage ratio of 8.04 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, MDEVICE Co., Ltd posted a return on equity (ROE) of 28.24, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 15.60 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 15.22, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 20.95, useful for judging operating efficiency across full business cycles. The company generates approximately 4.33B in revenue per employee across its workforce of 23.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.94 indicates how many times MDEVICE Co., Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, MDEVICE Co., Ltd recorded 3.36B in income tax expense. That works out to an effective tax rate of 20.71, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 16.21B, leaving 13.01B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, MDEVICE Co., Ltd's stock has declined approximately 41.30% over the past 52 weeks. The 50-day moving average sits at 12,783.60, while the 200-day moving average is 18,057.25.

Over the twelve months ended June 30, 2026, MDEVICE Co., Ltd generated 99.65B in revenue and converted that into 13.01B in net income, yielding earnings per share of 1,145.10. EBITDA reached 15.64B, while operating income came in at 14.10B.

As of June 30, 2026, MDEVICE Co., Ltd holds 31.44B in cash and equivalents against 34.76B in total debt, resulting in a net debt position of 5.18B. Total book value stands at 53.01B, with working capital of 33.83B providing operational flexibility.

MDEVICE Co., Ltd produced -3.24B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -7.29B in capital expenditures, free cash flow totaled -10.52B - equivalent to -987.84 per share.

Over the twelve months ended June 30, 2026, MDEVICE Co., Ltd posted a gross margin of 18.13, reflecting its pricing power and cost economics. The operating margin of 14.15 and net profit margin of 13.05 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -7.16: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -26.29, meaning MDEVICE Co., Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, MDEVICE Co., Ltd has an Altman Z-Score of 3.14, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.